Change over period: —
NSE · MAXHEALTH
MAXHEALTH
-13.4% from the 52-week high · +25.5% above the low
Max Healthcare Institute Ltd. engages in the management and operation of hospitals and specialty clinics. The firm operates through the Medical and Healthcare Services segment. The firm also operates a homecare business and pathology business under the brand names Max@Home and Max Lab. Max@Home offers health and wellness services at home. Max Lab provides pathology services outside its hospital network. The firm is specialized in providing treatment for cancer care/oncology, cardiac sciences, endocrinology and diabetes, eye care/ophthalmology, gastroenterology, hepatology and endoscopy, laparoscopic/minimal access surgery, neurosciences, liver transplant and biliary sciences, orthopedics and joint replacement, bariatric surgery/metabolic, robotic surgery, kidney transplant, bone marrow transplant, urology, and vascular surgery. The firm owns, operates and provides medical services to facilities in Delhi, Mumbai, Punjab, Uttar Pradesh and Uttarakhand. The company has approximately 17 healthcare facilities.
The short version. MAXHEALTH reported revenue of ₹2,569 crore for Sep 2026, up 20.3% from a year earlier. Net profit was ₹415 crore (down 15.5% year on year). Return on equity was 13.4% in Mar 2026. Promoter holding was 23.71% in Sep 2026, down 0.03 points over 8 quarters.
1 · The price
How has the stock traded?
MAXHEALTH trades 13.4% below its 52-week high and 25.5% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹2,569 cr.
Sep 2026 net profit of ₹415 cr.
6.8 pts lower than a year earlier.
Revenue compounded at 22.0% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2569 | 2366 | 2143 | 2068 | 2135 | 2028 | 1910 | 1868 |
| Net profit | 415 | 323 | 342 | 301 | 491 | 308 | 319 | 239 |
| Net margin % | 16.2 | 13.6 | 16.0 | 14.6 | 23.0 | 15.2 | 16.7 | 12.8 |
| EPS (₹) | 4.26 | 3.32 | 3.52 | 3.09 | 5.05 | 3.17 | 3.28 | 2.46 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 8373 | 7028 | 5406 | 4563 | 3931 | 2505 |
| Net profit | 1442 | 1076 | 1058 | 1104 | 605 | -137 |
| Net margin % | 17.2 | 15.3 | 19.6 | 24.2 | 15.4 | -5.5 |
| EPS (₹) | 14.82 | 11.07 | 10.88 | 11.37 | 6.24 | -1.42 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 13.4% in Mar 2026; debt to equity is 0.32.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 13.4 | 11.5 | 12.6 | 14.9 |
| Return on capital % | 12.7 | 11.7 | 13.3 | 12.7 |
| EBITDA margin % | 27.6 | 26.9 | 29.9 | 29.3 |
| Net margin % | 16.9 | 15.0 | 18.9 | 23.5 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 22.0% | 26.7% |
| Profit CAGR | 9.3% | — |
4 · The owners
Who holds it, and are they adding?
Down 0.03 pts over 8 quarters.
Down 16.41 pts over 8 quarters.
Up 15.45 pts over 8 quarters.
+90 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 23.74 | 23.74 | 23.74 | 23.74 | 23.72 | 23.71 | 23.71 | 23.71 | -0.03 |
| FII | 56.93 | 54.74 | 54.76 | 51.8 | 50.55 | 45.39 | 41.78 | 40.52 | -16.41 |
| DII | 15.55 | 17.58 | 17.42 | 20.03 | 21.2 | 26.32 | 29.96 | 31.0 | +15.45 |
| Public | 3.77 | 3.94 | 4.08 | 4.43 | 4.52 | 4.57 | 4.56 | 4.76 | +0.99 |
Mutual fund holdings · Oct 2026
308 schemes hold this stock
218 the month before.
- Groww BSE Hospitals ETF18.92% of NAV
- Invesco India Pharma and Healthcare Fund8.59% of NAV
- Invesco India Mid cap Fund7.86% of NAV
- Invesco India Large & Mid Cap Fund6.88% of NAV
- Bandhan Healthcare Fund5.56% of NAV
- ICICI Prudential Nifty Healthcare ETF5.55% of NAV
- Axis NIFTY Healthcare ETF5.55% of NAV
- DSP Nifty Healthcare ETF5.55% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for MAXHEALTH are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Corporate actions
Recent dividends, bonuses and splits
- 03 Jul 2026 · Final Dividend - Rs. 2
- 04 Jul 2025 · Final Dividend - Rs. 1.5
- 23 Aug 2024 · Final Dividend - Rs. 1.5
- 08 Sep 2023 · Final Dividend - Rs. 1
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.